TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Oslo Cancer Cluster Incubator AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
11,184
|
11,608
|
10,431 |
| Financial expenses |
5
|
3
|
9 |
| Earnings before taxes |
1,139
|
663
|
-263 |
| Total assets |
7,500
|
6,810
|
7,100 |
| Current assets |
6,410
|
5,758
|
6,078 |
| Current liabilities |
1,151
|
1,085
|
1,628 |
| Equity capital |
6,350
|
5,725
|
5,472 |
| - share capital |
1,462
|
1,540
|
1,640 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
84.7%
|
84.1%
|
77.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
10.2%
|
5.7%
|
-2.5% |
| Return on assets (ROA) |
15.3%
|
9.8%
|
-3.6% |
| Current ratio |
556.9%
|
530.7%
|
373.3% |
| Return on equity (ROE) |
17.9%
|
11.6%
|
-4.8% |
| Change turnover |
159
|
1,818
|
90 |
| Change turnover % |
1%
|
19%
|
1% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.